The Federal Trade Commission on Friday sued prescription-drug middlemen ... agrees with the FTC’s point that “PBMs have ...

The FTC accused the companies of creating a “perverse” drug rebate system that prioritizes insulin from manufacturers sold at a higher list price even when cheaper versions are available.

FTC Sues Drug Middlemen Over Manipulating Insulin Market Lower-cost versions of insulin weren’t covered by group plans Drug benefit managers accused of illegally inflating prices ...

according to the FTC. They also allegedly used the allure of rebates to lure new clients. The agency contends that even when lower drug priced insulin was available, the PBMs "systemically ...

The Federal Trade Commission on Friday sued prescription-drug middlemen owned by CVS Health Corp., Cigna Group and UnitedHealth Group Inc., alleging that they artificially pumped up prices of ...

The US Federal Trade Commission sued units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. on Friday, accusing the drug middlemen of ... conflict between the FTC and the three ...